Inventory / revenue moved 718 bp lower
Inventory / revenue changed -718 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory / revenue changed -718 basis points from the comparable as-filed period.
Current liabilities changed +20.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Free-cash-flow margin changed +12575 basis points from the comparable as-filed period.
Operating cash-flow margin changed +10723 basis points from the comparable as-filed period.
R&D / revenue changed -6943 basis points from the comparable as-filed period.
Research & development changed -14.9% from the comparable as-filed period.
Trade receivables changed -16.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current ratio changed +22.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Receivables / revenue changed -7956 basis points from the comparable as-filed period.
Working capital / assets changed +777 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.